QuintilesIMS, Vice President and Head of the Neuroscience Center of Excellence
Dr. Kalali is currently the Global Head of the Neuroscience Center of Excellence at QuintilesIMS. In this role, he is responsible for the enterprise-wide strategy for neuroscience, encompassing clinical development and health care services. Over the last twenty years, he has been responsible for numerous successful clinical development programs that have led to new treatments for patients.
He is Professor at University of California San Diego, Faculty at Singularity University, and BART X Medicine. He is an advisor to the Center for Digital Transformation at the Paul Merage School of Business at the University of California, Irvine.
Dr. Kalali is the Editor of the journal Innovations in Clinical Neuroscience, and the Lead Editor of the book Essential CNS Drug Development, published by Cambridge University Press. He has authored over 200 peer-reviewed publications.
He has been involved in initiatives by the Institute of Medicine Forum on Drug Discovery, Development, and Translation, as well as the NIH FAST and the NIH NCATS New Therapeutic Uses program.
Dr. Kalali regularly presents at national and international scientific meetings, and lectures on product development, innovation, technology, digital medicine and health.
In 2005, 2006 and 2008 and 2011 and 2012 PharmaVOICE magazine named Dr. Kalali as one its 100 most inspiring leaders in the life sciences as voted by his peers. In 2014 he was honored with the PharmaVOICE Inaugural Red Jacket award, recognizing those who have been most lauded by their peers since the awards began.